Arrowhead Pharmaceuticals (ARWR) Q3 2018 Earnings

7AugConfirmed
Q4 2017
Q1 2018
Q2 2018
Q3 2018
-0.19
-0.16
-0.12
-0.09

Details

Expected EPS
-0.18
Actual EPS
-0.18
Surprise EPS
0
Surprise Percent
+0%

Description

Arrowhead Pharmaceuticals (ARWR) has reported earnings of -0.18 per share for Q3 2018.

0 Comments

Share your thoughts